Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Cefiderocol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 25,681Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Shionogi Highlights Cefiderocol Role In Diverse Infections
    Shionogi Highlights Cefiderocol Role In Diverse Infections

    20 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-20/idweek-2025-shionogi-presents-real-world-and-surveillance-data-reinforcing-role-of-cefiderocol-acro

    PHARMIWEB
    20 Oct 2025
    Share Share
    Shionogi Unveils Anti-Infective Portfolio Data at IDWeek
    Shionogi Unveils Anti-Infective Portfolio Data at IDWeek

    03 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-03/shionogi-to-present-new-data-from-anti-infective-portfolio-at-idweek

    PHARMAWEB
    03 Sep 2025
    Share Share
    Shionogi's cefiderocol improves outcomes in early gram-negative i
    Shionogi's cefiderocol improves outcomes in early gram-negative i

    30 Apr 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/shionogis-cefiderocol-shows-improved-outcomes-with-early-use-in-treating-gram-negative-infections-globaldata/

    EXPRESSPHARMA
    30 Apr 2025
    Share Share
    Shionogi Presents Real-World Evidence Study Of Cefiderocol At IDWeek
    Shionogi Presents Real-World Evidence Study Of Cefiderocol At IDWeek

    16 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241016051716/en

    BUSINESSWIRE
    16 Oct 2024
    Share Share
    ESCMID 2024: Shionogi Presents Fetcroja Real-World Efficacy Data
    ESCMID 2024: Shionogi Presents Fetcroja Real-World Efficacy Data

    18 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240418017364/en

    BUSINESSWIRE
    18 Apr 2024
    Share Share
    Shionogi Presents Evidence Demonstrating Effectiveness of Fetroja
    Shionogi Presents Evidence Demonstrating Effectiveness of Fetroja

    11 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231010481450/en

    BUSINESSWIRE
    11 Oct 2023
    Share Share